Clinical Trials for Ovarian Clear Cell Adenocarcinoma

Find clinical trials for ovarian clear cell adenocarcinoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT ID: NCT05231122

This clinical trial is studying a new treatment approach for women with recurrent ovarian cancer, specifically looking at how well pembrolizumab and bevacizumab work together, with or without an ad...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States, Houston, Texas, United States

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

NCT ID: NCT05950464

This clinical trial is looking at the safety and effectiveness of two drugs, M1774 and ZEN-3694, when used together to treat women with recurrent ovarian and endometrial cancer. The goal is to find...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cleveland, Ohio, United States, Milwaukee, Wisconsin, United States +12 more

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

NCT ID: NCT04919629

This clinical trial is studying new treatment options for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer, particularly in cases where there is a buildup of fluid and can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

A Phase 1 Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer

NCT ID: NCT05226507

This clinical trial is studying a new treatment called NXP800 in patients with advanced cancers, particularly focusing on those with certain types of ovarian cancer that have a specific genetic mut...

Recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, Miami Beach, Florida, United States +24 more

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

NCT ID: NCT04575935

The LANCE Trial is a study looking at two types of surgery for women with advanced ovarian, primary peritoneal, or fallopian tube cancer. The trial compares minimally invasive surgery (MIS), which ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +5 more

AMT-151 in Patients With Selected Advanced Solid Tumours

NCT ID: NCT05498597

This clinical trial is investigating a new treatment called AMT-151 for patients with certain advanced cancers, including various types of ovarian, endometrial, lung, breast, and pancreatic cancers...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fuzhou, Fujian, China, Sydney, New South Wales, Australia +7 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions